Showing results (21-30 of 205) with videos related to
Sort By:
Pageof 21
Expert Opinion on Investigational Drugs|July 2, 2005
Olanzapine (Zyprexa):characteristics of a new antipsychoticC A Tamminga, J M KanePsychopharmacology|January 1, 1979
Treatment of Schizophrenia with ergot derivativesC A Tamminga, M H SchafferNeuroscience|July 28, 2015
Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiologyC A Tamminga, R S ZukinDialogues in Clinical Neuroscience|October 29, 2011
Treatments for chronic psychosisC A Tamminga, A C LahtiExpert Opinion on Investigational Drugs|July 2, 2005
Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychoticJ M Kane, C A TammingaSynapse (New York, N.Y.)|August 1, 1996
Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time courseX M Gao, C A TammingaThe Journal of Clinical Psychiatry|January 1, 1997
The application of neuroimaging techniques to drug developmentC A Tamminga, R R ConleyPeptides|May 1, 1982
Brain endopeptidase generates enkephalin from striatal precursorsM Knight, C Plotkin, C A TammingaNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 1998
Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidolX M Gao, K Sakai, C A TammingaEuropean Journal of Pharmacology|May 18, 1984
Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolismG Lucignani, L J Porrino, C A TammingaPageof 21